Tendon Stiffness With Age Clinical Trial
Official title:
Interactions of Muscle-Tendon Mechanics During Stair Climbing and Trip Recovery, and Efficacy of Collagen Supplementation for Functional Improvement for Older Adults
| Verified date | March 2023 |
| Source | Liverpool John Moores University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Older adults are at higher risks of tripping and falling than young adults. These falls may lead to serious injuries (bone fractures, head trauma…) and premature death. They also have an important economic cost for the society. One of the reasons identified for this increased risk of falling is the modification of muscles and tendons functional and architectural parameters with age. It is now well established that muscles of older adults are smaller and weaker, while tendons, that modulate the outcomes of muscle contraction, are less able to resist to tension and transmit forces more slowly than in young age. These changes have functional implications, especially in tasks that require to quickly generate high forces, such as recovering from a trip. This study aims to determine the links between muscle-tendon characteristics and locomotion, and to understand whether they can be improved by a four-months collagen supplementation. The investigators will measure the muscular strength and tendon stiffness of lower limb musculotendinous units (MTU) for older adults using isokinetic dynamometry (IKD) and ultrasounds. Participants' abilities to recover from a trip will then be evaluated using a custom built tripping device while walking on a treadmill (participants will wear a whole body harness attached to a rope secured to the ceiling). These performances will be linked to MTU characteristics and compared between both age groups. Finally, the investigators will evaluate the effect of a nutritional supplementation on the mechanical properties of elderly tendons and its potential impacts on their ability to safely recover from a trip, on their lean mass, and on other life quality related markers (joint pain, balance, stair climbing capacities...). The investigators expect that this study will lead to a new intervention aiming to improve the safety of older adults performing their daily activities using nutritional supplementation, which is known to have better adherence than training interventions.
| Status | Completed |
| Enrollment | 21 |
| Est. completion date | June 15, 2021 |
| Est. primary completion date | June 15, 2021 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 50 Years and older |
| Eligibility | Inclusion Criteria: - Men and women over 50 years - Mean age: maximum 65 years Exclusion Criteria: - Any lower limb injury in the last 6 months - A joint replacement - Neural, musculoskeletal or balance disorder that could affect the musculoskeletal system or capacity to execute functional tasks - Be taking any nutritional supplements that affect muscle or tendon size or function or stopped its intake less than 3 months before the baseline - Presence of systemic diseases (e.g., diabetes mellitus or cardiovascular, kidney, liver or lung disease) - Pregnant or breast feeding - History of drug abuse - Taking anti-inflammatory medication within 24 hours the baseline - Allergic to any ingredient in the test products (meat, fish or soy) - Concurrent participation in other clinical studies - Taking medication to treat a chronic disease (e.g., rheumatoid arthritis, psoriatic arthritis, fibromyalgia, gout and inflammatory joint disease for example bursitis or tennis elbow, and any other type of chronic pain syndrome other than osteoarthritis) |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Liverpool John Moores University - Tom Reilly Building | Liverpool |
| Lead Sponsor | Collaborator |
|---|---|
| Liverpool John Moores University |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Tendon stiffness | Tendon stiffness will be measured as the change in tendon length per change in tendon force. Tendon lengthening will be measured using B-mode ultrasound as the displacement of the proximal insertion (myotendinous junction (MTJ) for the Achilles tendon and patellar insertion for the patellar tendon) during maximum voluntary contractions. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Rate of torque development (RTD) | RTD is dependant of tendon stiffness and is measured as the gradient of the torque-time curve during isometric contractions. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Muscles strength | Muscle strength will be measured during isometric and isokinetic (concentric) contractions and will be used to plot the force-velocity profile of each participant. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Muscle length | Muscle length will be measured at rest using B-mode ultrasounds images captured at the proximal and distal insertions. Muscle length will be measured as the straight line between these 2 points. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Fascicle length | Fascicle length will be measured using B-mode ultrasounds. Ultrasound images will be captured at the mid belly of the muscle. Fascicle length will be defined as the straight line distance between the upper and the lower aponeurosis parallel to the lines of collagenous tissue. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Muscle cross sectional area | Cross sectional area will be measured at rest using B-mode ultrasounds. Transversal-planed images will be captured. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Pennation angle | Pennation angle will be measured using B-mode ultrasounds. Ultrasound images will be captured at the mid belly of the muscle. Pennation angle will be defined at the angle between the fascicle and the lower aponeurosis. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Tendon length | Tendons length will be measured at rest using B-mode ultrasounds. Tendon length will be measured as the distance between the proximal and the distal ends. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Tendon cross sectional area | Cross sectional area will be measured at rest using B-mode ultrasounds. Tendon cross sectional area will be measured by transversal plane scanning at 25, 50 and 75% of tendon length. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | EMG (Electromyography) activity | EMG activity will be measured during muscle contractions using electrodes placed on the skin. EMG activity represents the electric activity of a muscle. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Electromechanical delay | Electromechanical delay will be measured during muscle contractions using electrodes placed on the skin. The electromechanical delay (EMD) corresponds to the time latency between the beginning of muscle activation and the beginning of moment development, quantified by visual inspection of the EMG and force-time traces. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Whole body bone mineral density | Bone mineral density will be measured using DXA (Dual-energy X-ray absorptiometry) scan | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Lean mass | Lean mass will be measured using the same DXA (Dual-energy X-ray absorptiometry) scan | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Balance | Berg balance scale, which is a test aiming to evaluate balance among older people, will be used to evaluate objectively participants balance while performing different tasks (standing with eyes closed, standing on one foot, retrieving object from floor…). Each task is evaluated on 4 points: such as 4 points represent a good balance and 0 point a poor balance. Fourteen tasks have to be completed with a total score of 56. Participants ranging from 0 to 20 are considered as being at high risk of falling (poor balance), those ranging from 21 to 40 as being at medium risk of falling and those ranging from 41 to 56 as low risk of falling (good balance).
Total score: Scores for each task will be summed to obtain the total score. MAXIMUM total score = 56. |
at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Participants' confidence for activities-specific balance tasks | Participants' confidence for activities-specific balance tasks will be evaluated using the ABC-scale (activities specific balance confidence scale): they will have to rate their balance confidence for performing activities by answering to the question 'How confident are you that you will not lose your balance or become unsteady when you…' for several tasks such as walking around the house, walking up or down stairs… For each activity, participants will have to indicate their level of confidence in doing the activity without losing their balance or becoming unsteady from choosing one of the percentage points on the scale from 0% to 100% (0% represents no confidence and 100% represents complete confidence).
Percentages obtain for each question (total 16 questions) will be summed and the total divided by 16 to obtain each subject's ABC score. |
at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Knee scoring scale | Lysholm Knee Scoring Scale questionnaire will be used to evaluate how participants' knee problems have affected their ability to manage in everyday life. For each question they will have to choose the answer that best applies to them at the moment. The total score is the sum of each response to the questions, and may range from 0-100. Higher scores indicate a better outcome with fewer symptoms or disability. Lower scores indicate a worse outcome with more symptoms or disability. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Joints pain | A numerical rating scale (NRS) will be used to evaluate participants' joints pain.
They will first have to answer (Yes or No) to the question: Do you usually suffer from any joint pain? If the answer is YES, they will have to specify which joints are usually painful and where appropriate which side. Joints investigated are the following: shoulder, elbow, wrist, hand, back, lower back, neck, hip, knee, ankle and foot. For each painful joint (and each side), participants will have to rate from 0 to 100 the amount of pain they had in the last 24 hours. 0 being no pain at all and 100 the worst pain possible. |
at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Participants' perceived risk of falling | The fall efficacy scale international (FES-I) will be used to measure participants' perceived risk of falling. Participants will have to answer to the question "How concerned are you about the possibility of falling when you are…?" for 16 items. For each item, the score goes from 1 to 4, 1 being not at all concerned, 2 being somewhat concerned, 3 being fairly concerned and 4 being very concerned. The sum of all scores gives a maximum total of 64 points. A higher score indicates a greater fear of falling. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Participants' health perception | The Nottingham Health Profile will be used to measure participants' health perception. It provides a brief indication of participants' perceived emotional, social and physical health problems. The questionnaire is composed of 38 questions for which participants have to answer "Yes" or "No" in 6 subareas (energy level, pain, sleep, social isolation, physical abilities and emotional reaction). A weighted value is assigned to each question. The sum of all weighted values in a given subarea adds up to 100. The higher the score, the greater the number and severity of problems. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: step length | Step length will be quantified from the kinematic data obtained during trip recovery | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: margin of stability | Margin of stability during trip recovery will be measured using the centre of pressure displacement. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: number of steps required to be back to baseline | Number of steps required to be back to baseline margin of stability will be measured using a motion capture system. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: joint moments | Joint moments during trip recovery will be measured using kinematic and kinetic data obtained during the gait analysis | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: joint power | Joint power during trip recovery will be measured using kinematic and kinetic data obtained during the gait analysis | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: EMG activity | EMG activity of lower limb muscles (gastrocnemius, quadriceps, soleus, biceps femoris) will be measured using electrodes placed on the skin. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Trip recovery: MTJ displacement | Musculotendinous junction (MTJ) displacement will be measured during trip recovery using B-mode ultrasound images. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Stair climbing: centre of pressure to centre of mass distance | Centre of pressure to centre of mass distance during stair climbing will be measured from the kinematic data obtained during stair climbing. | at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Stair climbing: pain level | Participants' degree of pain while using the staircase will be evaluated using a numerical rating scale.
They will first have to answer by Yes or No to the question: Now that you have used the staircase, did it trigger any joint pain? If yes, they will have to specify which joint was painful, and where appropriate which side. Joints investigated are the following: back, lower back, hip, knee, ankle and foot. For each painful joint (and each side), participants will have to rate from 0 to 100 their amount of pain while climbing stairs. 0 being no pain at all and 100 the worst pain possible. |
at baseline and after the end of the supplementation period (4-months) | |
| Secondary | Stair climbing: confidence level | Participants' confidence when using the staircase will be evaluated using a numerical rating scale.
Participants will have to answer to the questions: Before starting the stair climbing trials: How confident are you that you can go up and down the stairs without falling? After the stair climbing trials: Now that you have used the staircase, how confident were you that you would not fall while using it? They will answer on a scale from 0 to 10, 0 being not confident at all and 10 being completely confident. |
at baseline and after the end of the supplementation period (4-months) |